Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
4.0
-171.64%
40%
—
17x
60%
—
5 Years
Score4.0
Net Growth-171.64%
Net Trend40%
Net Income Consistency—
Rev Growth17x
Rev Trend60%
Revenue Consistency—
Plus Therapeutics Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 303K to $ 5M and net income went from -$ 8M to -$ 22M. Revenue increased in 3 of those 5 years; net income in 2.
Between 2005 and 2025, revenue declined from $ 6M to $ 5M and net income went from -$ 26M to -$ 22M. Revenue increased in 9 of those 20 years; net income in 10.
Plus Therapeutics Inc currently holds a 20-year HDB Score of 2.7 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-07 | $ 3.84 | — |
1 Year2025-08-12 | $ 18.27 | -78.99% |
5 Years2021-08-12 | $ 761.25 | -99.50% |
10 Years2016-08-12 | $ 384.38K | -100.00% |
20 Years2006-08-11 | $ 1000K | -100.00% |
| Period | Last Price2026-08-07 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 |
|---|---|---|---|---|---|
| Price | $ 3.84 | $ 18.27 | $ 761.25 | $ 384.38K | $ 1000K |
| Return | — | -78.99% | -99.50% | -100.00% | -100.00% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 5M | -$ 22M | $ 8M |
| 2024 | $ 5M | -$ 12M | $ 3M |
| 2023 | $ 4M | -$ 13M | $ 8M |
| 2022 | $ 224K | -$ 20M | $ 18M |
| 2021 | $ 0.00 | -$ 13M | $ 18M |
| 2020 | $ 303K | -$ 8M | $ 8M |
| 2019 | $ 6M | -$ 10M | $ 17M |
| 2018 | $ 2M | -$ 12M | $ 5M |
| 2017 | $ 6M | -$ 22M | $ 9M |
| 2016 | $ 11M | -$ 22M | $ 12M |
| 2015 | $ 11M | -$ 18M | $ 14M |
| 2014 | $ 7M | -$ 37M | $ 14M |
| 2013 | $ 12M | -$ 26M | $ 15M |
| 2012 | $ 14M | -$ 32M | $ 25M |
| 2011 | $ 9M | -$ 32M | $ 36M |
| 2010 | $ 10M | -$ 27M | $ 52M |
| 2009 | $ 14M | -$ 23M | $ 12M |
| 2008 | $ 6M | -$ 30M | $ 12M |
| 2007 | $ 6M | -$ 28M | $ 11M |
| 2006 | $ 7M | -$ 25M | $ 12M |
| 2005 | $ 6M | -$ 26M | $ 15M |
| 2004 | $ 6M | -$ 2M | $ 13M |
| 2003 | $ 14M | -$ 9M | $ 14M |
| 2002 | $ 9M | -$ 13M | $ 24M |
| 2001 | $ 5M | -$ 11M | $ 33M |
| IPO2000 | $ 6M | -$ 8M | $ 44M |
Explore beyond PSTV
You're looking at Plus Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
